Drug Cos. Deride FTC's Lidoderm, Opana Antitrust Suit
Endo, Allergan and Impax on Friday said the U.S. Federal Trade Commission could not pursue claims in a Pennsylvania federal court that the companies unlawfully delayed generic drug competition for Opana...To view the full article, register now.
Already a subscriber? Click here to view full article